Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1319 |
|
| Actual shortage: | 60 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1223 (93%) | |
Discontinuation Reports |
287 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 283 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
210 (13%) |
|
Overdue reports |
27 (44%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2022-10-14 | 2023-02-24 | 171759 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2019-09-18 | 2020-04-09 | 94269 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2017-06-16 | 2017-12-18 | 13118 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2017-07-25 | 2018-05-05 | 17063 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2017-09-19 | 2018-11-29 | 22795 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2017-11-10 | 2018-02-19 | 28841 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Avoided shortage | 2018-04-20 | 2018-09-19 | 46725 |
| PMS-OLANZAPINE | 10MG | TABLET | Resolved | 2018-01-26 | 2018-06-29 | 37291 |
| PMS-OLANZAPINE | 2.5MG | TABLET | Resolved | 2018-01-26 | 2018-06-29 | 37294 |
| PMS-OLANZAPINE | 5MG | TABLET | Resolved | 2018-02-12 | 2018-10-18 | 39534 |
| PMS-OLANZAPINE | 7.5MG | TABLET | Resolved | 2018-02-12 | 2018-05-18 | 39537 |
| PMS-OLANZAPINE | 20MG | TABLET | Resolved | 2018-03-19 | 2020-06-10 | 43351 |
| PMS-OLANZAPINE | 10MG | TABLET | Resolved | 2022-10-31 | 2023-01-09 | 173167 |
| PMS-OLANZAPINE | 10MG | TABLET | Resolved | 2023-02-21 | 2023-08-07 | 185238 |
| PMS-OLANZAPINE | 15MG | TABLET | Resolved | 2023-07-10 | 2023-10-16 | 198015 |
| PMS-OLANZAPINE | 15MG | TABLET | Resolved | 2019-03-29 | 2019-06-11 | 79866 |
| PMS-OLANZAPINE | 2.5MG | TABLET | Resolved | 2019-09-18 | 2019-11-19 | 94272 |
| PMS-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-03-07 | 2018-06-29 | 42102 |
| PMS-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-03-19 | 2018-06-07 | 43354 |
| PMS-OLMESARTAN | 40MG | TABLET | Resolved | 2018-04-20 | 2018-08-24 | 46744 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-DIGOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |